Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
REVERSE TARGETING LIPID VESICLE
Document Type and Number:
WIPO Patent Application WO/2008/026781
Kind Code:
A1
Abstract:
Disclosed is a immunomodulating agent or a therapeutic agent for an immune disease, which comprises a lipid vesicle including therein a substance capable of inhibiting or killing an immunocyte that expresses or binds to an antibody and having an antigen for the antibody bound to the outer surface thereof. It becomes possible to provide a means for treating an immune disease such as an allergic disease and autoimmune disease effectively.

Inventors:
OKU, Naoto (21-11, Kawahara-cho Shimizu-ku, Shizuoka-sh, Shizuoka 57, 4240857, JP)
奥直人 (〒57 静岡県静岡市清水区川原町21-11 Shizuoka, 4240857, JP)
ASAI, Tomohiro (21-11, Kawahara-cho Shimizu-ku, Shizuoka-sh, Shizuoka 57, 4240857, JP)
Application Number:
JP2007/067449
Publication Date:
March 06, 2008
Filing Date:
August 31, 2007
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ASTELLAS PHARMA INC. (3-11, Nihonbashi Hon-cho 2-chome Chuo-k, Tokyo 11, 1038411, JP)
アステラス製薬株式会社 (〒11 東京都中央区日本橋本町2-3-11 Tokyo, 1038411, JP)
OKU, Naoto (21-11, Kawahara-cho Shimizu-ku, Shizuoka-sh, Shizuoka 57, 4240857, JP)
奥直人 (〒57 静岡県静岡市清水区川原町21-11 Shizuoka, 4240857, JP)
International Classes:
A61K45/00; A61K9/127; A61K39/385; A61P37/02; A61P37/06; A61P37/08; A61P43/00
Attorney, Agent or Firm:
KOBAYASHI, Hiroshi et al. (IKUBO & KATAYAMAFukuoka Bldg. 9th Fl.,8-7, Yaesu 2-chome,Chuo-k, Tokyo 28, 1040028, JP)
Download PDF: